Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

Clinical trial NCT03983226 · RECRUITING

Trial details

NCT number: NCT03983226
Sponsor: Shanghai Gynecologic Oncology Group
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Recurrent Fallopian Tube Cancer Primary Peritoneal Carcinoma

Start date: 2019-10-18
Primary completion: 2025-06-01
Enrollment: 167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.